Registry and health insurance claims data in vascular research and quality improvement

被引:28
作者
Behrendt, Christian-Alexander
Heidemann, Franziska
Riess, Henrik Christian
Stoberock, Konstanze
Debus, Sebastian Eike
机构
[1] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr Hamburg, Hamburg, Germany
[2] GermanVasc, Dept Vasc Med, Hamburg, Germany
关键词
Registry; administrative data; health insurance claims data; data validity; quality improvement; routine data; ABDOMINAL AORTIC-ANEURYSM; ADMINISTRATIVE DATA; ROUTINE DATA; MORTALITY; OUTCOMES;
D O I
10.1024/0301-1526/a000589
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The expansion of procedures in multidisciplinary vascular medicine has sparked a controversy regarding measures of quality improvement. In addition to primary registries, the use of health insurance claims data is becoming of increasing importance. However, due to the fact that health insurance claims data are not collected for scientific evaluation but rather for reimbursement purposes, meticulous validation is necessary before and during usage in research and quality improvement matters. This review highlights the advantages and disadvantages of such data sources. A recent comprehensive expert opinion panel examined the use of health insurance claims data and other administrative data sources in medicine. Results from several studies concerning the validity of administrative data varied significantly. Validity of these data sources depends on the clinical relevance of the diagnoses considered. The rate of implausible information was 0.04%, white the validity of the considered diagnoses varied between 80 and 97 % across multiple validation studies. A matching study between health insurance claims data of the third-largest German health insurance provider, DAK-Gesundheit, and a prospective primary registry of the German Society for Vascular Surgery demonstrated a good level of validity regarding the mortality of endovascular and open surgical treatment of abdominal aortic aneurysm in German hospitals. In addition, a large-scale international comparison of administrative data for the same disorder presented important results in treatment reality, which differed from those from earlier randomized controlled trials. The importance of administrative data for research and quality improvement wilt continue to increase in the future. When discussing the internal and external validity of this data source, one has to distinguish not only between its intended usage (research vs. quality improvement), but also between the included diseases and/or treatment procedures. Linkage between primary registry data and administrative data could be a reasonable solution to some current major issues of validity.
引用
收藏
页码:11 / 15
页数:5
相关论文
共 22 条
[1]  
[Anonymous], GUTACHTEN DATEN VERS
[2]  
AOK-Bundesverband FEISA Helios-Kliniken, 2007, QUALITATSSICHERUNG E
[3]  
Behrendt CA, 2016, CHARING CROSS 2016 V
[4]   Big Data in Medical Science- a Biostatistical View Part 21 of a Series on Evaluation of Scientific Publications [J].
Binder, Harald ;
Blettner, Maria .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2015, 112 (09) :137-142
[5]   Measuring the quality of surgical care: Structure, process, or outcomes? [J].
Birkmeyer, JD ;
Dimick, JB ;
Birkmeyer, NJO .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 198 (04) :626-632
[6]  
Braun B, 2006, SCHRIFTENREIHE GESUN, V51
[7]   Perioperative mortality following repair for abdominal aortic aneurysm in Germany. Comparison of administrative data of the DAK health insurance and clinical registry data of the German Vascular Society [J].
Debus, E. S. ;
Torsello, G. ;
Behrendt, C. -A. ;
Petersen, J. ;
Grundmann, R. T. .
CHIRURG, 2015, 86 (11) :1041-1049
[8]   The validity of routine data on quality assurance. A qualitative systematic review [J].
Hanisch, E. ;
Weigel, T. F. ;
Buia, A. ;
Bruch, H. -P. .
CHIRURG, 2016, 87 (01) :56-61
[9]   Validation of SHI Claims Data Exemplified by Gender-specific Diagnoses [J].
Hartmann, J. ;
Weidmann, C. ;
Biehle, R. .
GESUNDHEITSWESEN, 2016, 78 (10) :E53-E58
[10]   Validation of secondary data. Strengths and limitations [J].
Hoffmann, F. ;
Andersohn, F. ;
Giersiepen, K. ;
Scharnetzky, E. ;
Garbe, E. .
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2008, 51 (10) :1118-1126